drugset / Trial / NCT07385248
A Clinical Trial to Assess the Pharmacokinetics and Safety of AD-229 Compared to AD-2291 in Healthy Adults
RandomizedCrossoverOpen-labelTreatment
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics between the administration of AD-229 and the administration of AD-2291 in healthy adults.
Timeline
- Start
- 2026-04
- Primary completion
- 2026-06
- Completion
- 2026-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rebamipide | Small molecule | 100 mg | Oral |
| Subject | Rebamipide | Small molecule | 300 mg | Oral |